My former employer, Bristol-Myers Squibb Co., has announced it is selling its ConvaTec unit for $4.1 billion to two private equity firms:  Nordic Capital and Avista Capital Partners.  ConvaTec had been Bristol-Myers’ ostomy and surgical equipment.

Apparently, cash will be used to help finance Bristol-Myers’s strategy to shift its focus to biopharmaceuticals.